CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

The Role of Connected Inhalers in Improving Usability and Adherence in Respiratory Disease

Recent data suggest that 339M people globally have asthma, resulting in 425,000 deaths annually, many of which would be preventable with access to medication and appropriate healthcare. Even in countries with high standards of living, well established healthcare systems, and proper medication availability, unnecessary deaths still occur. In fact, a recent report suggests that around twothirds of asthma deaths are preventable in the UK. Although several factors contribute to a failure to manage treatment effectively, Iain Simpson at Phillips-Medisize states why failure to take medication as prescribed is a key issue.

 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026